|
Vol. 273, Issue 4, 2008-2014, January 23, 1998
Role of the CCAAT/Enhancer Binding Protein- Transcription
Factor in the Glucocorticoid Stimulation of p21waf1/cip1 Gene
Promoter Activity in Growth-arrested Rat Hepatoma Cells
Erin J.
Cram,
Ross A.
Ramos,
Edward C.
Wang,
Helen H.
Cha,
Yukihiro
Nishio, and
Gary L.
Firestone
From the Department of Molecular and Cell Biology and The Cancer
Research Laboratory, University of California,
Berkeley, California 94720
The preceding paper (Cha, H. H., Cram,
E. J., Wang, E. C., Huang, A. J., Kasler, H. G.,
and Firestone, G. L. (1998) J. Biol. Chem. 273, 0000-0000(478563) defined a glucocorticoid responsive region within
the promoter of the p21 CDK inhibitor gene that contains a putative
DNA-binding site for the transcription factor CCAAT/enhancer binding
protein- (C/EBP ). Wild type rat BDS1 hepatoma cells as well as
as4 hepatoma cells, which express antisense sequences to C/EBP and
ablate its protein production, were utilized to investigate the role of
this transcription factor in the glucocorticoid regulation of p21 gene
expression. The stimulation of p21 protein levels and promoter
activity, as well as inhibition of CDK2-mediated retinoblastoma protein
phosphorylation, by the synthetic glucocorticoid, dexamethasone,
required the expression of C/EBP . Overexpression of C/EBP in as4
cells rescued the dexamethasone responsiveness of the p21 promoter.
Site-directed mutagenesis of the p21 promoter revealed that
dexamethasone stimulation of p21 promoter activity required
the C/EBP consensus DNA-binding site. Furthermore, in glucocorticoid receptor-defective EDR1 hepatoma cells, dexamethasone failed to stimulate C/EBP and p21 protein expression and promoter activities. Our results have established a functional link between the
glucocorticoid receptor signaling pathway that mediates a G1 cell cycle arrest of rat hepatoma cells and the
transcriptional control of p21 by a cascade that requires the steroid
induction of C/EBP gene expression.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Johansson-Haque, E. Palanichamy, and S. Okret
Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP
J. Mol. Endocrinol.,
October 1, 2008;
41(4):
239 - 249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Inoue, N. Yahagi, T. Yamamoto, M. Ishikawa, K. Watanabe, T. Matsuzaka, Y. Nakagawa, Y. Takeuchi, K. Kobayashi, A. Takahashi, et al.
Cyclin-dependent Kinase Inhibitor, p21WAF1/CIP1, Is Involved in Adipocyte Differentiation and Hypertrophy, Linking to Obesity, and Insulin Resistance
J. Biol. Chem.,
July 25, 2008;
283(30):
21220 - 21229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-C. Lin, J.-H. Lin, C.-W. Chou, Y.-F. Chang, S.-H. Yeh, and C.-C. Chen
Statins Increase p21 through Inhibition of Histone Deacetylase Activity and Release of Promoter-Associated HDAC1/2
Cancer Res.,
April 1, 2008;
68(7):
2375 - 2383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Q. Yang, J. J. Rudiger, J. M. Hughes, S. Goulet, M. M. Gencay-Cornelson, P. Borger, M. Tamm, and M. Roth
Cell Density and Serum Exposure Modify the Function of the Glucocorticoid Receptor C/EBP Complex
Am. J. Respir. Cell Mol. Biol.,
April 1, 2008;
38(4):
414 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. H. Choi, C. G. Kim, Y.-S. Bae, Y. Lim, Y. H. Lee, and S. Y. Shin
p21Waf1/Cip1 Expression by Curcumin in U-87MG Human Glioma Cells: Role of Early Growth Response-1 Expression
Cancer Res.,
March 1, 2008;
68(5):
1369 - 1377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koschmieder, F. D'Alo, H. Radomska, C. Schoneich, J. S. Chang, M. Konopleva, S. Kobayashi, E. Levantini, N. Suh, A. Di Ruscio, et al.
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha
Blood,
November 15, 2007;
110(10):
3695 - 3705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Harms, K. Albrecht, U. Harms, K. Seidel, L. Hauck, T. Baldinger, D. Hubner, G. Kronenberg, J. An, K. Ruscher, et al.
Phosphatidylinositol 3-Akt-Kinase-Dependent Phosphorylation of p21Waf1/Cip1 as a Novel Mechanism of Neuroprotection by Glucocorticoids
J. Neurosci.,
April 25, 2007;
27(17):
4562 - 4571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Li, Y. Chen, D. Cao, Y. Wang, G. Chen, S. Zhang, and J. Lu
Glucocorticoid Up-Regulates Transforming Growth Factor-{beta} (TGF-{beta}) Type II Receptor and Enhances TGF-{beta} Signaling in Human Prostate Cancer PC-3 Cells
Endocrinology,
November 1, 2006;
147(11):
5259 - 5267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yin and J. Glass
In Prostate Cancer Cells the Interaction of C/EBP{alpha} with Ku70, Ku80, and Poly(ADP-ribose) Polymerase-1 Increases Sensitivity to DNA Damage
J. Biol. Chem.,
April 28, 2006;
281(17):
11496 - 11505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Woltje, B. Tschoke, V. von Bulow, R. Westenfeld, B. Denecke, S. Graber, and W. Jahnen-Dechent
CCAAT enhancer binding protein beta and hepatocyte nuclear factor 3beta are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expression.
J. Mol. Endocrinol.,
April 1, 2006;
36(2):
261 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Paz-Priel, D. H. Cai, D. Wang, J. Kowalski, A. Blackford, H. Liu, C. A. Heckman, A. F. Gombart, H. P. Koeffler, L. M. Boxer, et al.
CCAAT/Enhancer Binding Protein {alpha} (C/EBP{alpha}) and C/EBP{alpha} Myeloid Oncoproteins Induce Bcl-2 via Interaction of Their Basic Regions with Nuclear Factor-{kappa}B p50
Mol. Cancer Res.,
October 1, 2005;
3(10):
585 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Chikanza and D. L. Kozaci
Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives
Rheumatology,
November 1, 2004;
43(11):
1337 - 1345.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Smith, W. J. Freebern, I. Collins, A. De Siervi, I. Montano, C. M. Haggerty, M. C. McNutt, W. G. Butscher, I. Dzekunova, D. W. Petersen, et al.
Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment
PNAS,
August 10, 2004;
101(32):
11554 - 11559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Roth, P. R.A. Johnson, P. Borger, M. P. Bihl, J. J. Rudiger, G. G. King, Q. Ge, K. Hostettler, J. K. Burgess, J. L. Black, et al.
Dysfunctional Interaction of C/EBP{alpha} and the Glucocorticoid Receptor in Asthmatic Bronchial Smooth-Muscle Cells
N. Engl. J. Med.,
August 5, 2004;
351(6):
560 - 574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schrem, J. Klempnauer, and J. Borlak
Liver-Enriched Transcription Factors in Liver Function and Development. Part II: the C/EBPs and D Site-Binding Protein in Cell Cycle Control, Carcinogenesis, Circadian Gene Regulation, Liver Regeneration, Apoptosis, and Liver-Specific Gene Regulation
Pharmacol. Rev.,
June 1, 2004;
56(2):
291 - 330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. N. Cassel and M. Nord
C/EBP transcription factors in the lung epithelium
Am J Physiol Lung Cell Mol Physiol,
October 1, 2003;
285(4):
L773 - L781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shim and R. C. Smart
Lithium Stabilizes the CCAAT/Enhancer-binding Protein {alpha} (C/EBP{alpha}) through a Glycogen Synthase Kinase 3 (GSK3)-independent Pathway Involving Direct Inhibition of Proteasomal Activity
J. Biol. Chem.,
May 23, 2003;
278(22):
19674 - 19681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Urban, T. Golden, I. V. Aragon, L. Cowsert, S. R. Cooper, N. M. Dean, and R. E. Honkanen
Identification of a Functional Link for the p53 Tumor Suppressor Protein in Dexamethasone-induced Growth Suppression
J. Biol. Chem.,
March 7, 2003;
278(11):
9747 - 9753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Fingerle-Rowson, P. Koch, R. Bikoff, X. Lin, C. N. Metz, F. S. Dhabhar, A. Meinhardt, and R. Bucala
Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo
Am. J. Pathol.,
January 1, 2003;
162(1):
47 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Y. Wu, H. Chen, S. E. Wang, C. M. J. apRhys, G. Liao, M. Fujimuro, C. J. Farrell, J. Huang, S. D. Hayward, and G. S. Hayward
CCAAT/Enhancer Binding Protein {alpha} Interacts with ZTA and Mediates ZTA-Induced p21CIP-1 Accumulation and G1 Cell Cycle Arrest during the Epstein-Barr Virus Lytic Cycle
J. Virol.,
December 20, 2002;
77(2):
1481 - 1500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Greenberg, J. Hu, S. Basu, J. Hay, J. Reibman, T.-a. Yie, K. M. Tchou-Wong, W. N. Rom, and T. C. Lee
Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators
Am. J. Respir. Cell Mol. Biol.,
September 1, 2002;
27(3):
320 - 328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Pereira, Y. Li, W. T. Gunning, P. M. Kramer, F. Al-Yaqoub, R. A. Lubet, V. E. Steele, E. Szabo, and L. Tao
Prevention of mouse lung tumors by budesonide and its modulation of biomarkers
Carcinogenesis,
July 1, 2002;
23(7):
1185 - 1192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. CROCHEMORE, T. M. MICHAELIDIS, D. FISCHER, J.-P. LOEFFLER, and O. F. X. ALMEIDA
Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation
FASEB J,
June 1, 2002;
16(8):
761 - 770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Stockand
New ideas about aldosterone signaling in epithelia
Am J Physiol Renal Physiol,
April 1, 2002;
282(4):
F559 - F576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. RUDIGER, M. ROTH, M. P. BIHL, B. C. CORNELIUS, M. JOHNSON, R. ZIESCHE, and L.-H. BLOCK
Interaction of C/EBP{alpha} and the glucocorticoid receptor in vivo and in nontransformed human cells
FASEB J,
February 1, 2002;
16(2):
177 - 184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Zahnow, R. D. Cardiff, R. Laucirica, D. Medina, and J. M. Rosen
A Role for CCAAT/Enhancer Binding Protein {beta}-Liver-enriched Inhibitory Protein in Mammary Epithelial Cell Proliferation
Cancer Res.,
January 1, 2001;
61(1):
261 - 269.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J.-S. Park, L. Qiao, D. Gilfor, M. Y. Yang, P. B. Hylemon, C. Benz, G. Darlington, G. Firestone, P. B. Fisher, and P. Dent
A Role for Both Ets and C/EBP Transcription Factors and mRNA Stabilization in the MAPK-dependent Increase in p21 Cip-1/WAF1/mda6 Protein Levels in Primary Hepatocytes
Mol. Biol. Cell,
September 1, 2000;
11(9):
2915 - 2932.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. A. Slomiany, K. L. D'Arigo, M. M. Kelly, and D. T. Kurtz
C/EBPalpha Inhibits Cell Growth via Direct Repression of E2F-DP-Mediated Transcription
Mol. Cell. Biol.,
August 15, 2000;
20(16):
5986 - 5997.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Bossis and T. E. Porter
Ontogeny of Corticosterone-Inducible Growth Hormone-Secreting Cells during Chick Embryonic Development
Endocrinology,
July 1, 2000;
141(7):
2683 - 2690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Park, S. Boyer, K. Mitchell, D. Gilfor, M. Birrer, G. Darlington, W. El Deiry, G. L. Firestone, K. Munger, V. Band, et al.
Expression of Human Papilloma Virus E7 Protein Causes Apoptosis and Inhibits DNA Synthesis in Primary Hepatocytes via Increased Expression of p21Cip-1/WAF1/MDA6
J. Biol. Chem.,
January 7, 2000;
275(1):
18 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Park, S. Carter, D. B. Reardon, R. Schmidt-Ullrich, P. Dent, and P. B. Fisher
Roles for Basal and Stimulated p21Cip-1/WAF1/MDA6 Expression and Mitogen-activated Protein Kinase Signaling in Radiation-induced Cell Cycle Checkpoint Control in Carcinoma Cells
Mol. Biol. Cell,
December 1, 1999;
10(12):
4231 - 4246.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. K. R. Samuelsson, A. Pazirandeh, B. Davani, and S. Okret
p57Kip2, a Glucocorticoid-Induced Inhibitor of Cell Cycle Progression in HeLa Cells
Mol. Endocrinol.,
November 1, 1999;
13(11):
1811 - 1822.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Quaroni, J. Q. Tian, M. Goke, and D. K. Podolsky
Glucocorticoids have pleiotropic effects on small intestinal crypt cells
Am J Physiol Gastrointest Liver Physiol,
November 1, 1999;
277(5):
G1027 - G1040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Pan, C. J. Hetherington, and D.-E. Zhang
CCAAT/Enhancer-binding Protein Activates the CD14 Promoter and Mediates Transforming Growth Factor beta Signaling in Monocyte Development
J. Biol. Chem.,
August 13, 1999;
274(33):
23242 - 23248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Rogatsky, A. B. Hittelman, D. Pearce, and M. J. Garabedian
Distinct Glucocorticoid Receptor Transcriptional Regulatory Surfaces Mediate the Cytotoxic and Cytostatic Effects of Glucocorticoids
Mol. Cell. Biol.,
July 1, 1999;
19(7):
5036 - 5049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. O'Rourke, G. C. Newbound, J. A. Hutt, and J. DeWille
CCAAT/Enhancer-binding Protein delta Regulates Mammary Epithelial Cell G0 Growth Arrest and Apoptosis
J. Biol. Chem.,
June 4, 1999;
274(23):
16582 - 16589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Lange, J. K. Richer, and K. B. Horwitz
Hypothesis: Progesterone Primes Breast Cancer Cells for Cross-Talk with Proliferative or Antiproliferative Signals
Mol. Endocrinol.,
June 1, 1999;
13(6):
829 - 836.
[Full Text]
|
 |
|

|
 |

|
 |
 
T. W. H. Li, J. Wang, J. T. Lam, E. M. Gutierrez, R. S. Solorzano-Vargus, H. V. Tsai, and M. G. Martin
Transcriptional control of the murine polymeric IgA receptor promoter by glucocorticoids
Am J Physiol Gastrointest Liver Physiol,
June 1, 1999;
276(6):
G1425 - G1434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Timchenko, M. Wilde, and G. J. Darlington
C/EBPalpha Regulates Formation of S-Phase-Specific E2F-p107 Complexes in Livers of Newborn Mice
Mol. Cell. Biol.,
April 1, 1999;
19(4):
2936 - 2945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Ramos, W. J. Meilandt, E. C. Wang, and G. L. Firestone
Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant
FASEB J,
January 1, 1999;
13(1):
169 - 180.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. M. Christoffels, T. Grange, K. H. Kaestner, T. J. Cole, G. J. Darlington, C. M. Croniger, and W. H. Lamers
Glucocorticoid Receptor, C/EBP, HNF3, and Protein Kinase A Coordinately Activate the Glucocorticoid Response Unit of the Carbamoylphosphate Synthetase I Gene
Mol. Cell. Biol.,
November 1, 1998;
18(11):
6305 - 6315.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. H. Cha, E. J. Cram, E. C. Wang, A. J. Huang, H. G. Kasler, and G. L. Firestone
Glucocorticoids Stimulate p21 Gene Expression by Targeting Multiple Transcriptional Elements within a Steroid Responsive Region of the p21waf1/cip1 Promoter in Rat Hepatoma Cells
J. Biol. Chem.,
January 23, 1998;
273(4):
1998 - 2007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Smith, R. A. Redman, C. R. Logg, G. A. Coetzee, N. Kasahara, and B. Frenkel
Glucocorticoids Inhibit Developmental Stage-specific Osteoblast Cell Cycle. DISSOCIATION OF CYCLIN A-CYCLIN-DEPENDENT KINASE 2 FROM E2F4-p130 COMPLEXES
J. Biol. Chem.,
June 23, 2000;
275(26):
19992 - 20001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Elberg, J. M. Gimble, and S. Y. Tsai
Modulation of the Murine Peroxisome Proliferator-activated Receptor gamma 2 Promoter Activity by CCAAT/Enhancer-binding Proteins
J. Biol. Chem.,
September 1, 2000;
275(36):
27815 - 27822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hong, S. J. Park, H. J. Kong, J. D. Shuman, and J. Cheong
Functional Interaction of bZIP Proteins and the Large Subunit of Replication Factor C in Liver and Adipose Cells
J. Biol. Chem.,
July 20, 2001;
276(30):
28098 - 28105.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|